Page 55 - 2018_12-Haematologica-web

TWIST1 regulates normal hematopoiesis and leukemia
References
1. Mendez-FerrerS,MichurinaTV,FerraroF,et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature. 2010;466(7308):829-834.
2. Zhang J, Niu C, Ye L, et al. Identification of the haematopoietic stem cell niche and con-
trol of the niche size. Nature. 2003;425(6960):836-841.
3. Arai F, Hirao A, Ohmura M, et al. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell. 2004;118(2):149- 161.
4. Ding L, Saunders TL, Enikolopov G, Morrison SJ. Endothelial and perivascular cells maintain haematopoietic stem cells. Nature. 2012;481(7382):457-462.
5. MorrisonSJ,ScaddenDT.Thebonemarrow niche for haematopoietic stem cells. Nature. 2014;505(7483):327-334.
6. SugiyamaT,KoharaH,NodaM,Nagasawa T. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell nich- es. Immunity. 2006;25(6):977-988.
7. Greenbaum A, Hsu YM, Day RB, et al. CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell main- tenance. Nature. 2013;495(7440):227-230.
8. StierS,KoY,ForkertR,etal.Osteopontinis a hematopoietic stem cell niche component that negatively regulates stem cell pool size. J Exp Med. 2005;201(11):1781-1791.
9. ChengH,HaoS,LiuY,etal.Leukemicmar- row infiltration reveals a novel role for Egr3 as a potent inhibitor of normal hematopoiet-
ic stem cell proliferation. Blood. 2015;126(11):1302-1313.
10. Krause DS, Fulzele K, Catic A, et al. Differential regulation of myeloid leukemias by the bone marrow microenvironment. Nat Med. 2013;19(11):1513-1517.
11. ThisseB,elMessalM,Perrin-SchmittF.The twist gene: isolation of a Drosophila zygotic gene necessary for the establishment of dorsoventral pattern. Nucleic Acids Res. 1987;15(8):3439-3453.
12. Verzi MP, Anderson JP, Dodou E, et al. N- twist, an evolutionarily conserved bHLH protein expressed in the developing CNS, functions as a transcriptional inhibitor. Dev Biol. 2002;249(1):174-190.
13. ChenZF,BehringerRR.Twistisrequiredin head mesenchyme for cranial neural tube morphogenesis. Genes Dev. 1995;9(6):686- 699.
14. IsenmannS,ArthurA,ZannettinoAC,etal. TWIST family of basic helix-loop-helix tran- scription factors mediate human mesenchy- mal stem cell growth and commitment. Stem Cells. 2009;27(10):2457-2468.
15. GoodnoughLH,ChangAT,TreloarC,Yang J, Scacheri PC, Atit RP. Twist1 mediates repression of chondrogenesis by beta- catenin to promote cranial bone progenitor specification. Development. 2012;139(23): 4428-4438.
16. Hjiantoniou E, Iseki S, Uney JB, Phylactou LA. DNazyme-mediated cleavage of Twist transcripts and increase in cellular apoptosis. Biochem Biophys Res Commun. 2003;300 (1):178-181.
17. HowardTD,PaznekasWA,GreenED,etal. Mutations in TWIST, a basic helix-loop- helix transcription factor, in Saethre-
Chotzen syndrome. Nat Genet. 1997;15(1)
:36-41.
18. Mahmoud MM, Kim HR, Xing R, et al.
TWIST1 integrates endothelial responses to flow in vascular dysfunction and atheroscle- rosis. Circ Res. 2016;119(3):450-462.
19. Mammoto T, Jiang A, Jiang E, Mammoto A. Role of Twist1 phosphorylation in angio- genesis and pulmonary fibrosis. Am J Respir Cell Mol Biol. 2016;55(5):633-644.
20. Arthur A, Cakouros D, Cooper L, et al. Twist-1 enhances bone marrow mesenchy- mal stromal cell support of hematopoiesis by modulating CXCL12 expression. Stem Cells. 2016;34(2):504-509.
21. Schreck C, Istvanffy R, Ziegenhain C, et al. Niche WNT5A regulates the actin cytoskele- ton during regeneration of hematopoietic stem cells. J Exp Med. 2017;214(1):165-181.
22. Saez B, Ferraro F, Yusuf RZ, et al. Inhibiting stromal cell heparan sulfate synthesis improves stem cell mobilization and enables engraftment without cytotoxic condition- ing. Blood. 2014;124(19):2937-2947.
23. Pinho S, Lacombe J, Hanoun M, et al. PDGFRalpha and CD51 mark human nestin+ sphere-forming mesenchymal stem cells capable of hematopoietic progenitor cell expansion. J Exp Med. 2013;210(7):1351- 1367.
24. Nakamura Y, Arai F, Iwasaki H, et al. Isolation and characterization of endosteal niche cell populations that regulate hematopoietic stem cells. Blood. 2010;116(9):1422-1432.
25. Kunisaki Y, Bruns I, Scheiermann C, et al. Arteriolar niches maintain haematopoietic stem cell quiescence. Nature. 2013;502(7473):637-643.
26. Acar M, Kocherlakota KS, Murphy MM, et al. Deep imaging of bone marrow shows non-dividing stem cells are mainly perisinu- soidal. Nature. 2015;526(7571):126-130.
27. Ciuculescu MF, Park SY, Canty K, Mathieu R, Silberstein LE, Williams DA. Perivascular deletion of murine Rac reverses the ratio of marrow arterioles and sinusoid vessels and alters hematopoiesis in vivo. Blood. 2015;125(20):3105-3113.
34. Hanoun M, Zhang D, Mizoguchi T, et al. Acute myelogenous leukemia-induced sym- pathetic neuropathy promotes malignancy in an altered hematopoietic stem cell niche. Cell Stem Cell. 2014;15(3):365-375.
35. Krivtsov AV, Twomey D, Feng Z, et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL- AF9. Nature. 2006;442(7104):818-822.
36. Wang Y, Krivtsov AV, Sinha AU, et al. The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML. Science. 2010;327(5973):1650-1653.
37. Yen HY, Ting MC, Maxson RE. Jagged1 functions downstream of Twist1 in the spec- ification of the coronal suture and the for- mation of a boundary between osteogenic and non-osteogenic cells. Dev Biol. 2010;347(2):258-270.
38. Kamath BM, Stolle C, Bason L, et al. Craniosynostosis in Alagille syndrome. Am J Med Genet. 2002;112(2):176-180.
39. Kode A, Mosialou I, Manavalan SJ, et al. Foxo1-dependent induction of acute myeloid leukemia by osteoblasts in mice. Leukemia. 2016;30(1):1-13.
40. Kode A, Manavalan JS, Mosialou I, et al. Leukaemogenesis induced by an activating beta-catenin mutation in osteoblasts. Nature. 2014;506(7487):240-244.
41. Wang L, Zhang H, Rodriguez S, et al. Notch- dependent repression of miR-155 in the bone marrow niche regulates hematopoiesis in an NF-kappaB-dependent manner. Cell Stem Cell. 2014;15(1):51-65.
42. Kim YW, Koo BK, Jeong HW, et al. Defective Notch activation in microenvironment leads to myeloproliferative disease. Blood. 2008;112(12):4628-4638.
43. Ohki Y, Heissig B, Sato Y, et al. Granulocyte colony-stimulating factor promotes neovas- cularization by releasing vascular endothe- lial growth factor from neutrophils. FASEB J. 2005;19(14):2005-2007.
44. Raaijmakers MH, Mukherjee S, Guo S, et al. Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia. Nature. 2010;464(7290):852-857.
45. Zambetti NA, Ping Z, Chen S, et al. Mesenchymal inflammation drives genotox- ic stress in hematopoietic stem cells and pre- dicts disease evolution in human pre- leukemia. Cell Stem Cell. 2016;19(5):613-
28. Balderman SR, Li AJ, Hoffman CM, et al.
Targeting of the bone marrow microenvi-
ronment improves outcome in a murine
model of myelodysplastic syndrome. Blood. 2016;127(5):616-625. 627.
29. Ratajczak MZ. A novel view of the adult bone marrow stem cell hierarchy and stem cell trafficking. Leukemia. 2015;29(4):776- 782.
30. Ara T, Tokoyoda K, Sugiyama T, Egawa T, Kawabata K, Nagasawa T. Long-term hematopoietic stem cells require stromal cell-derived factor-1 for colonizing bone marrow during ontogeny. Immunity. 2003;19(2):257-267.
46. Chiang MY, Shestova O, Xu L, Aster JC, Pear WS. Divergent effects of supraphysio- logic Notch signals on leukemia stem cells and hematopoietic stem cells. Blood. 2013;121(6):905-917.
47. Bernasconi P, Farina M, Boni M, Dambruoso I, Calvello C. Therapeutically targeting SELF-reinforcing leukemic niches in acute myeloid leukemia: a worthy endeavor? Am J Hematol. 2016;91(5):507-517.
48. Huang MM, Zhu J. The regulation of normal and leukemic hematopoietic stem cells by niches. Cancer Microenviron. 2012;5(3):295-
31. Taichman RS, Emerson SG. Human
osteoblasts support hematopoiesis through
the production of granulocyte colony-stimu-
lating factor. J Exp Med. 1994;179(5):1677- 305.
1682.
32. Mayani H. A glance into somatic stem cell
biology: basic principles, new concepts, and clinical relevance. Arch Med Res. 2003;34(1):3-15.
33. Bowers M, Zhang B, Ho Y, Agarwal P, Chen CC, Bhatia R. Osteoblast ablation reduces normal long-term hematopoietic stem cell self-renewal but accelerates leukemia devel- opment. Blood. 2015;125(17):2678-2688.
49. Chen S, Zambetti NA, Bindels EM, et al. Massive parallel RNA sequencing of highly purified mesenchymal elements in low-risk MDS reveals tissue-context-dependent acti- vation of inflammatory programs. Leukemia. 2016;30(9):1938-1942.
50. Dong CY, Liu XY, Wang N, et al. Twist-1, a novel regulator of hematopoietic stem cell self-renewal and myeloid lineage develop- ment. Stem Cells. 2014;32(12):3173-3182.
haematologica | 2018; 103(12)
1979